Morphine Derivative Intermediate for Shorter, Higher-Yield Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing industrial production methods for morphine drugs face challenges such as land occupation, complex processes, high costs, and instability due to opium poppy cultivation, while total synthesis methods lack practical significance and scalability.
Innovation Solution
A novel intermediate and method involving specific secondary amine protection groups and a series of chemical reactions, including hydroxyl protection group removal, reduction, and cyclization, to enhance yield and simplify the synthesis process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If opium poppy cultivation is used for morphine production, then morphine drugs can be produced, but it occupies large amounts of farmland and has unstable supply due to diseases, pests, and climate factors
Solution Approach 1:
The patent replaces the agricultural cultivation system with a chemical synthesis system. Instead of relying on opium poppy farming which is affected by climate, diseases, and pests, the invention uses total synthesis methods to produce morphine drugs from chemical precursors, thereby eliminating the mechanical/agricultural dependency and achieving stable supply.
Solution Approach 2:
The patent changes the production parameters from agricultural cultivation parameters (land area, climate conditions, pest control) to chemical synthesis parameters (reaction conditions, catalysts, reagents). This parameter transformation enables controlled, stable production independent of environmental factors.
2Quantity of substance
If traditional extraction and semi-synthesis methods are used, then morphine drugs can be produced, but the production process is complex and costly
Solution Approach 1:
The patent segments the complex traditional production process into distinct modular steps: synthesis of key intermediates, formation of the morphine skeleton, and derivation of specific morphine drugs. This segmentation simplifies each step and makes the overall process more manageable and cost-effective.
Solution Approach 2:
The patent introduces key intermediate compounds as mediators in the synthesis pathway. These intermediates serve as bridges between simple starting materials and the complex morphine drug molecules, enabling stepwise construction and simplifying the overall synthesis process compared to direct complex transformations.
3Adaptability or versatility
If total synthesis methods are used, then land occupation is avoided, but the synthesis process is lengthy and yields are low
Solution Approach 1:
The patent performs preliminary synthesis of key intermediates with optimized structures and properties before forming the final morphine skeleton. This preliminary action allows for better control of subsequent reactions, improving overall yield and reducing the length of the synthesis pathway.
Solution Approach 2:
The patent optimizes reaction parameters such as temperature, pressure, catalyst concentration, and reagent ratios to maximize synthesis yield. By carefully controlling these parameters at each step, the patent achieves high yields despite the multiple steps involved in total synthesis.
4Adaptability or versatility
If existing total synthesis methods are used, then land occupation is avoided, but the control process is long and procedures are complex
Solution Approach 1:
The patent merges multiple synthesis steps into convergent pathways where key intermediates are formed and then combined in fewer steps to produce the final morphine drug. This merging reduces the total number of operations and shortens the control process duration while maintaining land-use efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly improves the yield of morphine derivatives, reduces reaction steps, and decreases production costs, making it suitable for industrial-scale production.
Implementation Method 1
The patent employs oxidation reactions in the synthesis pathway, including the oxidation of phenolic compounds to quinone methides and other oxidized intermediates
Implementation Method 2
The patent employs reduction reactions in the synthesis pathway, including the reduction of carbonyl groups and other oxidized species
Implementation Method 3
The patent employs condensation reactions in the synthesis pathway to join molecular fragments and form larger structures
Data Source
AI summary
The present application relates to the field of drug synthesis, in particular to a novel intermediate, a method for preparing the same and application thereof. The structural formula of the novel intermediate provided by the present application is as expressed by formula I:where R is a secondary amine protection group. Based on the possible biogenic pathway of morphine derivatives, the present application realizes the efficient synthesis of morphine derivatives through the strategy of biomimetic synthesis, taking the asymmetric transfer hydrogenation reaction and the intramolecular oxidative dearomatization Heck reaction in the process of preparing the intermediate as the key reactions of total synthesis. Using the novel intermediate provided by the present application to synthesize morphine derivatives has the characteristics of significantly reducing the synthesis steps, improving the yield, reducing the discharge of three wastes and reducing the production cost.